Emergent BioSolutions (EBS) Tops Q4 EPS by 48c, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 48c, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.76 | 52 Week High | $44.38 | |||
| Open | $6.76 | 52 Week Low | $24.47 | |||
| Day High | $6.76 | P/E | 338.00 | |||
| Day Low | $6.76 | EPS | $0.02 | |||
| Volume | 144 | |||||
